A high drug failure rate is more than just a pattern recognition problem. Here's how we can address some of the root causes.
Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...
The current AI drug development “toolkit” For ease of ... it is a balance of factors, like the maturity of the field and the predictability of the relevant feature. Patent law jurisprudence ...
There is growing enthusiasm about China’s potential to speed up drug development with AI. And companies outside the country ...
drug discovery, development, manufacturing, and quality control. This collaboration combines the power of Microsoft’s secure Azure platform with the Tetra Scientific Data and AI Cloud ™ to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results